SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
64 hedge funds and large institutions have $52.4M invested in Sorrento Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 26 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
26% less capital invested
Capital invested by funds: $71.1M → $52.4M (-$18.6M)
46% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 26
Holders
64
Holding in Top 10
2
Calls
$33K
Puts
$44K
Top Buyers
| 1 | +$6.19M | |
| 2 | +$430K | |
| 3 | +$112K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$108K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$77K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$862K | |
| 3 | -$741K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$617K |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$568K |